Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Circulation|August 1, 1984
Safety of maximal exercise testing in patients at high risk for ventricular arrhythmiaD Z Young, S Lampert, T B Graboys, et al.Clinical Cardiology|January 1, 1997
The effect of atrial fibrillation and the ventricular rate control on exercise capacityR H Ostermaier, S Lampert, L Dalla Vecchia, et al.The American Journal of Cardiology|March 15, 1990
Assessment of the hemodynamic response to acetyl-strophanthidin by Doppler echocardiography in normal subjects and in those with coronary artery disease or idiopathic dilated cardiomyopathyH W Lange, S Lampert, M G Sutton, et al.American Heart Journal|October 1, 1992
The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular functionO Tschaidse, T B Graboys, B Lown, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2016
PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old miceJenna L Leclerc, Andrew S Lampert, Matthew A Diller, et al.Peptides|November 1, 1986
Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesityB G Stanley, S E Kyrkouli, S Lampert, et al.American Heart Journal|May 1, 1984
Long-term mexiletine for ventricular arrhythmiaJ Stein, P J Podrid, S Lampert, et al.American Heart Journal|May 1, 1986
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmiaG Hirsowitz, P J Podrid, S Lampert, et al.The European Journal of Neuroscience|April 8, 2015
Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhageJenna L Leclerc, Andrew S Lampert, Matthew A Diller, et al.The American Journal of Cardiology|October 16, 1987
Considerations of current methods for drug selection in treating malignant ventricular arrhythmiasB Lown, P J Podrid, T B Graboys, et al.Pageof 5